In February 18, 2006 few days after the latest clinical results with rimonabant were published in the Feb. 15 issue of the Journal of the American Medical Association, the Food and Drug Administration declined to approve this widely anticipated new …

Acomplia is a diet pill which acts as an appetite suppressant. Acomplia targets the CB1 receptors in the endocannabinoid system and blocks them. They are basically responsible for controlling your appetite as well as your urge to smoke. When ever …

Welcome to WordPress. This is your first post. Edit or delete it, then start blogging!